Prospective observational study on intestinal microbiota and gene mutations and gene expressions in colorectal cancer and inflammatory bowel disease

Prospective observational study on intestinal microbiota and gene mutations and gene expressions in colorectal cancer and inflammatory bowel disease - Prospective observational study on intestinal microbiota and gene mutations and gene expressions in colorectal cancer and inflammatory bowel disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036347

Enrollment

100

Registered

2019-03-29

Start date

2017-09-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer and inflammatory bowel disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: #1 Patients diagnosed colorectal cancer or inflammatory bowel disease by colonoscopy, computed tomography, and magnetic resonance imaging and scheduled to undergo surgery or colonoscopy. #2 Age of patient is over 20 years old. #3 Informed consent can be obtained.

Exclusion criteria

Exclusion criteria: #1 Informed consent can not be obtained. #2 Doctor recognizes that patient is not suitable for this study. #3 Cases in which the lesion is very small and subsequent pathological diagnosis is considered difficult.

Design outcomes

Primary

Measure	Time frame
The association of intestinal microbiota with gene mutations and gene expressions and clinicopathological factors in colorectal cancer and inflammatory bowel disease.	—

Countries

Japan

Contacts

Public ContactShozo Yokoyama

Wakayama Medical University Second Department of Surgery

yokoyama@wakayama-med.ac.jp073-441-0613

Outcome results